Clinical expression and antigenic profiles of a Plasmodium vivax vaccine candidate: merozoite surface protein 7 (PvMSP-7)

Vivax malaria is the predominant form of malaria outside Africa, affecting about 14 million people worldwide, with about 2.5 billion people exposed. Development of a Plasmodium vivax vaccine is a priority, and me...

Source: Malaria Journal - June 13, 2019 Category: Infectious Diseases Authors: Chew Weng Cheng, Somchai Jongwutiwes, Chaturong Putaporntip and Andrew P. Jackson Tags: Research Source Type: research